CR1 and rheumatoid arthritis: Our group revealed that although CR1 expression is markedly decreased on B cells of both active SLE and RA patients [10, 16], the inhibitory capacity of this complement receptor on RA B lymphocytes is maintained, and its ligand-induced clustering results in significant inhibition of B cell functions, similar to that found in the case of healthy individuals.